Tenofovir Treatment Duration Predicts Proteinuria in a Multiethnic United States Cohort of Children and Adolescents With Perinatal HIV-1 Infection
Murli Purswani, Russell B. Van Dyke(Tulane University), George K. Siberry(Columbia University Irving Medical Center), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Miriam C. Chernoff(Cancer Research And Biostatistics), Kunjal Patel(Harvard University), Rohan Hazra, George R. Seage(Unknown), Gwendolyn B. Scott, Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases)
Cited by 47
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856